GlassScriptPhysician profile
Brian Joseph Beatty
NPI 1194730689
$1,098.33
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $306 · 2021: $380 · 2022: $259 · 2023: $34.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $244.08 | 2019-2023 | |
| Vanda Pharmaceuticals INC. | $223.45 | 2020-2022 | |
| Gilead Sciences, INC. | $117.11 | 2020-2021 | |
| Lilly USA, LLC | $101.83 | 2020-2022 | |
| Viiv Healthcare Company | $57.42 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.94 | 2019-2022 | |
| Glaxosmithkline, LLC. | $49.29 | 2021-2023 | Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.15 | 2019-2021 | |
| Ibsa Pharma INC. | $32.38 | 2021-2022 | |
| Abbvie INC. | $26.55 | 2022 | |
| Abbott Laboratories | $24.91 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.80 | 2021 | |
| Dermira, INC. | $21.44 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.26 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.46 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $14.11 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.54 | 2022 | |
| Shire North American Group INC | $13.34 | 2019 | |
| Eisai INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.